La Sexta and Agencia Sinc, among other media, have published an article on the recent study by IRB Barcelona, led by ICREA researcher Lluís Ribas, who has discovered a mechanism that evolved in eukaryotic cells and that facilitates the synthesis of proteins, such as those present in the extracellular matrix. Of note, some of these proteins are highly relevant in biomedicine because of their link with diseases and greater knowledge of these molecules may bring about the development of strategies to inhibit their production, according to the authors.
Link to La Sexta
Link to Agencia Sinc
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to offer pioneering solutions to unresolved medical needs in cancer and other diseases related to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 employees and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).